Monday 28 September 2015
Fusion Antibodies’ Fsn1006h Bispecific antibody reaches development milestone and is awarded new European patent.
Wednesday 09 September 2015
Fusion Antibodies and Clarity Pharmaceuticals sign exclusive license agreement for Fusion’s Fsn0503 anti-Cathepsin antibody.
Wednesday 19 August 2015
Northern Ireland leads in National Digital Pathology Research Programme using Path XL Software